Adagene, Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies.

Biotechnology

Adagene

Adagene's headquarters in Suzhou Shi, China

Peter Luo

Ling Zhou

Man Kin Tam

Wenlin Zeng

Jiping Zha

Guizhong Liu

Yan Li

Qinghai Zhao

Zhu Li

Andy Cheung

Yumeng Wang

Mervyn Turner

Cuong Do

Min Li

The Corporate Development and Finance team at Adagene, Inc. is responsible for strategic financial planning, managing mergers and acquisitions, securing funding, and overseeing financial operations to support the company’s mission of developing novel antibody-based cancer immunotherapies. The team ensures financial stability and drives growth initiatives aligned with corporate objectives.

Corporate Development and Finance

This department oversees compliance and strategic direction through independent oversight from its directors.

Corporate Governance

The Research and Clinical Operations Team at Adagene, Inc. spearheads the discovery, development, and clinical evaluation of novel antibody-based cancer immunotherapies. This interdisciplinary team collaborates to integrate biology, pharmacology, bioinformatics, and clinical science to advance innovative treatment protocols from laboratory research through clinical trials.

Research and Clinical Operations Team

This department focuses on the chemistry, manufacturing, and controls of drug products, alongside toxicology and drug metabolism and pharmacokinetics.

CMC and Toxicology

This department manages investor relations and corporate communication strategies.

Investor Relations and Communications

This department focuses on strategic direction and decision-making for the organization.

Adagene

Org chart

Board & advisors

Teams

Corporate Development and Finance

Corporate Governance

Research and Clinical Operations Team

CMC and Toxicology

Investor Relations and Communications

Leadership Group

Offices

Adagene

Org chart

Board & advisors

Teams

Corporate Development and Finance

Corporate Governance

Research and Clinical Operations Team

CMC and Toxicology

Investor Relations and Communications

Leadership Group

Offices

Related companies